Singapore - engelsk - HSA (Health Sciences Authority)

aenon pharmaceuticals sea pte. ltd. - inactivated rabies virus (strain flury lep) - injection, powder, lyophilized, for solution - potency≥2.5iu - inactivated rabies virus (strain flury lep) potency≥2.5iu

Filippinene - engelsk - FDA (Food And Drug Administration)

zoetis philippines, inc.; distributor: zoetis philippines, inc. - inactivated rabies vaccine (vet.) - suspension for injection (im/sc) - formulation: each 1 ml (dose) contains: rabies virus (pv-paris, svr-289 strain) ... tcid - tissue culture infective dose ... > 107.35 tcid50 (before inactivation)

Kypros - gresk - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

zoetis hellas s.a. - ΖΏΝΤΑ ΕΞΑΣΘΕΝΗΜΈΝΑ ΙΌΣ ΤΗΣ ΝΌΣΟΥ ΤΟΥ carre, ΣΤΈΛΕΧΟΣ cdvu 39, ΖΏΝΤΩΝ ΕΞΑΣΘΕΝΗΜΈΝΩΝ canine ΑΔΕΝΟΪΌ ΤΎΠΟΥ 2, ΣΤΈΛΕΧΟΣ cav2-ΒΙΟ 13, ΖΏΝΤΩΝ ΕΞΑΣΘΕΝΗΜΈΝΩΝ ΚΥΝΙΚΌΣ ΠΑΡΒΟΪΌ, ΣΤΈΛΕΧΟΣ cpv-ΒΙΟ 12, ΖΏΝΤΩΝ ΕΞΑΣΘΕΝΗΜΈΝΩΝ canine parainfluenza ΤΎΠΟΥ 2 ΙΌΣ, ΣΤΈΛΕΧΟΣ cpiv-2-bio 15, ΑΔΡΑΝΟΠΟΙΗΜΈΝΟ leptospira interrogans ΟΡΌΤΥΠΟΥ iicterohaemorrhagiae, ΣΤΈΛΕΧΟΣ mslb 1008, ΑΔΡΑΝΟΠΟΙΗΜΈΝΟ leptospira interrogans ΟΡΌΤΥΠΟΥ canicola, ΣΤΈΛΕΧΟΣ mslb 1010, ΑΔΡΑΝΟΠΟΙΗΜΈΝΟ ΙΌ ΤΗΣ ΛΎΣΣΑΣ, ΣΤΈΛΕΧΟΣ ΘΛΙΒΕΡΉ vnukovo -32 - lyophilisate and solvent for suspenesion - 8900000262 - live attenuated canine distemper virus, strain cdvu 39 - 0 mg; 8900000263 - live attenuated canine adenovirus type 2, strain cav2-bio 13 - 0 mg; 8900000264 - live attenuated canine parvovirus, strain cpv-bio 12 - 0 mg; 8900000265 - live attenuated canine parainfluenza type 2 virus, strain cpiv-2-bio 15 - 0 mg; 8900000266 - inactivated leptospira interrogans serovar iicterohaemorrhagiae, strain mslb 1008 - 0 mg; 8900000267 - inactivated leptospira interrogans serovar canicola, strain mslb 1010 - 0 mg; 8900000082 - inactivated rabies virus, strain sad vnukovo -32 - 0 mg - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira

Tsjekkia - tsjekkisk - USKVBL (Ústav Pro Státní Kontrolu Veterinárních Biopreparátů A Léčiv)

bioveta, a.s. - Živé vakcíny viru psinky + živý psí adenovirus vakcína + živé parainfl.virus vakcíny + živý psí parvovirus vakcíny + inaktivovaná vakcína proti vzteklině + inaktivovaná leptospira vakcíny - lyofilizát a rozpouštědlo pro injekční suspenzi - Živé a inaktivované virové a bakteriální vakcíny - psi

Den europeiske union - norsk - EMA (European Medicines Agency)

zoetis belgium sa - valpesyke virus, belastning cdv bio 11/en, hjørnetann adenovirus type 2, belastning cav-2 bio 13, parvovirus type 2b, belastning cpv-2b bio 12/b, hjørnetann parainfluensa type 2-virus, belastning cpiv-2 bio 15 (alle levende svekket), leptospira interrogans serogruppe australis serovar bratislava, belastning mslb 1088, l. interrogans serogruppe icterohaemorrhagiae serovar icterohaemorrhagiae, belastning mslb 1089, l. interrogans serogruppe canicola serovar canicola, belastning mslb 1090, l. kirschneri serogruppe grippotyphosa serovar grippotyphosa, belastning mslb 1091... - live valpesyke virus + live hjørnetann adenovirus + live parainfl.viruset + live parvovirus + inaktivert rabies + inaktivert leptospira, immunologicals for canidae - hunder - aktiv vaksinasjon av hunder fra 8-9 ukers alder:for å forhindre dødelighet og kliniske tegn forårsaket av valpesyke virus,for å forhindre dødelighet og kliniske tegn forårsaket av hund adenovirus type 1,for å hindre kliniske tegn og redusere viral utskillelse forårsaket av hund adenovirus type 2,for å hindre kliniske tegn, leucopoenia og viral utskillelse forårsaket av parvovirus,for å hindre kliniske tegn (nese og okulær utslipp) og redusere viral utskillelse forårsaket av hund parainfluensa virus,for å hindre kliniske tegn, infeksjon og urinutskillelse forårsaket av l. interrogans serogruppe australis serovar bratislava,for å hindre kliniske tegn og urinutskillelse og redusere infeksjon forårsaket av l. interrogans serogruppe canicola serovar canicola og l. interrogans serogruppe icterohaemorrhagie serovar icterohaemorrhagiae,for å hindre kliniske tegn og redusere smitte og urinutskillelse forårsaket av l. interrogans serogruppe grippotyphosa serovar grippotyphosa og for å forhindre dødelighet, kliniske tegn og infeksjon forårsaket av rabiesvirus.

Den europeiske union - engelsk - EMA (European Medicines Agency)

zoetis belgium s.a. - canine parainfluenza virus, leptospira and rabies virus. - immunologicals for canidae, live and inactivated viral and bacterial vaccines - dogs - active immunization of dogs from six weeks of age to prevent clinical signs and reduce viral excretion cause by canine parainfluenza virus, to prevent clinical signs, infection and urinary excretion cause by leptospira serovars bratislava, canicola, grippotyphosa and icterohaemorrhagiae and to prevent mortality, clinical signs and infection cause by rabies virus.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - rabies virus -

Sveits - tysk - Tierarzneimittel Kompendium der Schweiz (Institut für Veterinärpharmakologie und toxikologie)

boehringer ingelheim (schweiz) gmbh - rabies virus, strain g52, inactivated - injektionssuspension für hunde, katzen, equiden, wiederkäuer und frettchen - rabies virus, strain g52, inactivated ≥ 2.09 log10 u., aluminii oxidum hydricum 1.7 mg, glasgow's minimal essentials medium, caseinum hydrolysatum, tryptose phosphate broth, natrii hydrogenocarbonas, acidum hydrochloridum, aqua ad iniectabile, ad suspensionem pro dosi 1 ml. - inaktivierter impfstoff gegen das tollwutvirus bei hunden, katzen, equiden, wiederkäuern und frettchen - impfstoffe

Storbritannia - engelsk - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - rabies virus - suspension for injection - inactivated viral vaccine - cats, dogs

Storbritannia - engelsk - VMD (Veterinary Medicines Directorate)

msd animal health uk limited - rabies virus - suspension for injection - inactivated viral vaccine - cats, dogs